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Abstract--A striking similarity exists between the pathogenetic properties of group 
A streptococci and those of activated mammalian professional phagocytes (neutro- 
phils, macrophages). Both types of cells are endowed by the ability to adhere to 
target cells; to elaborate oxidants, hydrolases, and membrane-active agents (hemo- 
lysins, phospholipases); and to freely invade tissues and destroy cells. From the 
evolutionary point of vew,  streptococci might justifiably be considered the forefathers 
of "mo d em"  leukocyl:es. Our earlier findings that synergy between a streptococcal 
hemolysin (streptolysin S, SLS) and a streptococcal thiol-dependent proteinase and 
between cytotoxic anlibodies + complement and streptokinase-activated plasmin 
readily killed tumor cells, led us to hypothesize that by analogy to the pathogenetic 
mechanisms of streptococci, the mechanisms of tissue destruction initiated by acti- 
vated leukocytes in inflammatory sites, as well as in tissues undergoing episodes of 
ischemia and reperfusion, might also be the result of the synergistic effects among 
leukocyte-derived oxidants, phospholipases, proteinases, cytokines, and cationic pro- 
teins. The current report extends our previous synergy studies with endothelial ceils 
to two additional cell types--monkey kidney epithelial cells and rat beating heart 
cells. Monolayers of 5~Cr-labeled cells that had been treated by combinations of 
sublytic amounts of hydrogen peroxide (generated either by glucose oxidase, xan- 
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thine-xanthine oxidase, or by pamquat) and with sublytic amounts of a variety of 
membrane-active agents (streptolysin S, phospholipases A2 and C, lysophosphatides, 
histone, chlorhexidine) were killed in a synergistic manner (double synergy). Crys- 
talline trypsin markedly enhanced cell killing by combinations of oxidant and the 
membrane-active agents (triple synergy). Injury to the cells was characterized by the 
appearance of large membrane blebs that detached from the cells and floated freely 
in the media, looking like lipid droplets. Cytotoxicity induced by the various com- 
binations of agonists was depressed, to a large extent, by scavengers of hydrogen 
peroxide (catalase, dimethyl thiourea, and by Mn 2+) but not by SOD or by defer- 
oxamine. When cationic agents were employed together with hydrogen peroxide, 
polyanions (heparin, polyanethole sulfonate) were also found to inhibit cell killing. 
It is proposed that in order to effectively combat the deleterious toxic effects of 
leukocyte-derived agonists on cells and tissues, antagonistic "cocktails" comprised 
of cationized catalase, cationized SOD, dimethylthiourea, Mn ~+ + glycine, protein- 
ase inhibitors, putative inhibitors of phospholipases, and polyanions might be con- 
cocted. The current literature on synergistic phenomena pertaining to mechanisms of 
cell and tissue injury in inflammation is selectively reviewed. 
I N T R O D U C T I O N  
A voluminous literature exists on the role played by microbial toxins (1-4), 
their enzymes (5), and cell-wall components (6, 7) as well as by complement 
components (8), activated leukocytes, their hydrolases, oxygen radicals, cationic 
proteins, and cytokines (9-16) in the pathogenesis of  infectious and inflamma- 
tory diseases. Because of  the great complexity of  the biochemical, pharmaco- 
logical, immunological, and pathological processes that are involved in 
inflammation, there is a tendency to investigate, in depth, the pathogenetic role 
played by one single agonist at a time, rather than develop models that analyze 
the effects of  multiple factors in the initiation o f  tissue damage. This approach 
is probably justified since the construction of  complex models might be fraught 
with many technical and interpretational difficulties. 
To shed more light on this important issue, it might be relevant to analyze 
the experimental models that have been employed to elucidate the pathways of  
pathogenesis o f  group A streptococcal infections (17, 18) as these might shed 
more light on the pathobiology of  inflammation. 
Group A streptococci are catalase-negative, hydrogen peroxide-producing 
microorganisms that are endowed with the ability to spread in tissues due to the 
action of  potent hydrolases (hyaluronidase, four DNase isozymes, ribonuclease, 
a lipoproteinase, NADase,  acid phosphatase, N-acetylglucosaminidase, an SH- 
dependent proteinase, streptokinase, which activates plasminogen to plasmin, 
neuraminidase, and numerous still-unidentified antigens with pathogenetic 
potential) (17, 18). A C5a-inactivating enzyme generated by this microorganism 
might affect neutrophil accumulation at sites o f  infection (19). 
Furthermore, streptococci synthesize two potent cardiotoxic cytolysins, 
streptolysins O (SLO) and S (SLS), and an erythrogenic toxin with pyrogenic, 
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mitogenic, immune-modulating, and cytotoxic properties (17, 20-24). Strepto- 
cocci also possess a membrane-associated, amphipathic, lipoteichoic acid (LTA) 
(25) that facilitates adhez:ence to cell surfaces (26) and the delivery of a variety 
of metabolites, including hydrogen peroxide, proteinases, as well as of the cell- 
bound SLS, which migh': all act, in concert, to kill cells (20, 23, 27). LTA also 
stimulates the generation of TNF (28) and activates complement (29). Therefore, 
streptococci bear a strilcng similarity to activated neutrophils or macrophages, 
which are also capable of adhering to cell surfaces (30, 31), of elaborating and 
delivering upon targets numerous hydrolases, phospholipases, oxidants, cyto- 
kines, and arachidonic a, zid metabolites, all of which might act in concert to kill 
cells and destroy tissues. Both PMNs and macrophages also freely migrate into 
and spread in tissues. 
Our studies on the mechanisms of cell and tissue injury induced by group 
A streptococci (17) showed that synergy between a streptococcal hemolysin 
(streptolysin S, SLS) and a thiol-dependent proteinase (32); among cytotoxic 
antibodies, complement, and streptokinase-activated plasmin (33); and among 
LTA-anti-LTA antibod!Les and complement (34, 35), killed mammalian ceils in 
vitro. These findings led us to hypothesize that, by analogy to the streptococcal 
models, the mechanisms of cell and tissue injury induced in inflammatory pro- 
cesses might perhaps also be the result of multiple synergistic interactions among 
leukocyte agents (oxidants, hydrolases, including phospholipases, cationic pro- 
teins, and serum factors). This assumption is further supported by a series of 
investigations showing that synergy between cationic bactericidal peptides and 
hydrogen peroxide was also highly cytocidal for mammalian cells (36-39). Fur- 
thermore, combinations of hydrogen peroxide, cationic polypeptides, phospho- 
lipases, microbial hemolysins, and proteinases killed endothelial cells (40) and 
epithelial cells (43), in a synergistic manner and also released large amounts of 
arachidonic acid metabclites from endothelial cells (42). Combinations between 
oxidants and a variety of proteinases (elastase, neutral proteinases) also killed 
target cells in a synergistic manner (43-45) and enhanced lung injury due to 
oxidants (43). We have also shown (46) that synergy among cationic polypep- 
tides, calcium ionophore, chemotactic factors, and lectins led to the generation 
of enhanced amounts of superoxide, hydrogen peroxide, and chemiluminescence 
by human neutrophils and suggested that the excessive generation of oxidants, 
under similar conditions, might represent models of tissue damage. Other studies 
have shown that neutrophils and macrophages "primed" either by chemotactic 
peptides (47), LPS (48), lysophosphatides (49, 50), or by LTA (5!) generated 
synergistic amounts of hydrogen peroxide. In addition to the studies described 
above, an extensive literature exists on the role played by well-defined oxidants 
on cells and tissues in both in vitro and in vivo models. Only selected recent 
papers are quoted (9, 11-14, 52-60). 
There is also an increasing interest in the role played by oxidants as the 
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main  agonists  responsible  for induc ing  tissue damage  fol lowing ischemia and 
reperfusion o f  various organs (61, 62). A review o f  the clinical and experimental  
data on  this subject  (61-65)  strongly suggests that, by  analogy to the in vitro 
synergy,  models  described above,  cooperat ion among  oxidants,  phospholipases,  
proteinases,  cationic proteins,  and a variety of  other  agonists  derived from acti- 
vated leukocytes  might  also contr ibute  to extensive  tissue damage  seen fol lowing 
ischemia and  reperfusion episodes affecting a mult ipl ic i ty  of  organs.  
The  present  co mmu n i c a t i o n  further examines  synergy among  oxidants,  pro- 
teinases,  cationic proteins,  a streptococcal hemolys in ,  and phospholipases in the 
ki l l ing of  monkey  k idney epithelial  cells and beat ing rat heart  cells in  culture. 
The possibi l i ty  of  us ing  " c o ck t a i l s "  comprised o f  ant ioxidants ,  inhibitors o f  
proteinases and phosphol ipases ,  as well  as o f  polyanions ,  to combat  the dele- 
terious effects o f  the agonists  generated dur ing the inf lammatory process will be 
briefly discussed.  
M A T E R I A L S  A N D  M E T H O D S  
Culture Cells. Neonatal rat heart cultures were prepared as previously described (66). Mon- 
key kidney epithelial cells (BGM) were kindly supplied by Dr. Z. Ronnes of the Department of 
Virology, Hebrew University School of Medicine. The heart cells were cultivated in Ham F-10 
medium supplemented with 10% bovine serum and 10% horse serum. The epithelial cells were 
grown in D-MEM medium supplemented with glutamine, penicillin, and streptomycin and 10% 
fetal calf serum (45). Radiolabeled cell monolayers were prepared by the addition of 10/zCi/ml of 
[51Cr]NaCrO4 (New England Nuclear) to trypsinized cells grown in 75-ml tissue culture bottles. 
The ceils were then dispensed into 24-well tissue culture plates (Nunc, Roskilde, Denmark) and 
grown to confluency in a CO2 incubator. 
Reagents. Hydrogen peroxide flux was generated by the addition of various amounts of 
glucose oxidase (0.1-0.5 units/ml) to the tissue culture media. Hydrogen peroxide was also gen- 
erated either by a mixture of xanthine (5mM) and xanthine oxidase (0.066/ml) or by the addition 
of paraquat (1-10mM) (67) to the different media. The amount of superoxide generated was mea- 
sured by the SOD-inhibitable cytochrome c reduction assay (68). Hydrogen peroxide was assayed 
by the method of Thurman et al. (69). Streptolysin S (SLS) of group A streptococci (10-100 
hemolytic units/ml) (19), phospholipase C from Clostridium welchii (0.005-2.5 units/ml), phos- 
pholipase A2 (PLA2) either from bee venom (1-10 units/ml) or from Naja naja (1-20 units/ml) 
were employed as membrane-damaging agents. 
The streptococcal hemolysin and the phospholipases were also assayed by their ability to 
hemolyze red blood cells as described (22-24). To express the hemolytic and cytolytic activities of 
PLA2, 5 mg/ml of fatty acid-free albumin was added to the cultures 15 min after the addition of 
PLA 2. The fatty acids bound the enzymatically cleaved fatty acid and allowed the expression of the 
OD (3000 units/mg), soybean trypsin inhibitor (10,000 BAEE units/mg), dimethylthiourea (DMTU), 
MnC12, heparin, paraquat, and trypan blue (streptolysin S inhibitor) (22-24). All the reagents were 
purchased from Sigma Israel, Jerusalem, Israel. 
Chromium Release Assay. Culture monolayers were treated for different time intervals either 
with single agents or with combinations among the various agents listed above. The cultures were 
monitored periodically for changes in cell morphology. To assess cytotoxicity, the supernatant fluids 
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were removed and centrifuged at 2000 rpm for 2 min in Adams Sero-Fuge to eliminate detached 
cells (45). The solubilized radioactivity was then determined in a Contron gamma counter. The 
total radioactivity associated with untreated controls was solubilized by the addition of 1 ml of 1% 
Triton X-100. The net percentage release of radioactivity in the assay wells was determined by 
subtracting the radioactivity pn;sent in the supernatant fluids of the untreated controls. Cytotoxicity 
was also assayed by determining the release of lactic dehydrogenase (68). 
R E S U L T S  
Combined Effects cf  1-120 z, SLS, and Trypsin on BGM Cells. Figure 1 
shows that radiolabeled BGM cells exposed for 2 h at 37~ to a flux of  hydrogen 
peroxide lost only 1.0% of  the chromium label. Similarly,  exposure of  the cells 
to increasing concentrations of  SLS (10-100 units/ml) did not give rise either 
to visible cytopathic changes or  to a leak of  chromium from the cells. The 
morphological  patterns of  control untreated cells (Figure 2) and of  cells treated 
with glucose oxidase (GO), which only showed some cell rounding (Figure 3), 
support the data presen!:ed in Figure 1. On the other hand, the simultaneous 
presence of  hydrogen peroxide and SLS resulted in a distinct synergistic chro- 
mium release (Figure 1). The most striking morphological  changes occurred 
when SLS was combined with hydrogen peroxide,  where cell swelling and the 
appearance of  hyaline bi[ebs, usually in one pole of  the cell, took place (Figure 
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Fig. 1. Effect of streptolysin S (SLS) and glucose oxidase (GO) (0.5 units/ml) -generated hydrogen 
peroxide and crystalline trypsin (TPS) (25/zg/ml) on the killing (chromium release) of BGM cells. 
Note the synergistic chromium release induced by combinations among the various reactants. Mn 2+ 
(1 mM) totally inhibited the synergistic killing of the cells. The data are the average of 10 different 
experiments. 
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Fig. 2. BGM cells incubated for 90 rain in DMEM medium ( x 250). 
Fig. 3. BGM cells incubated for 90 min with GO (0.5 units/ml) (x250). 
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Fig. 4. BGM cells incubated For 90 min with mixtures of SLS (100 units/ml) and GO (0.5 units/ 
ml). Note the presence of large blebs (pseudopodlike structures) in one pole of the cells and the 
detachment of lipidlike droplel s, representing membrane damage (x 250). 
the ceils, forming numerous liposome-like structures that floated freely in the 
tissue culture media. T aese distinct cytopathogenic changes were essentially 
similar to those found by us when rat beating heart cultures were exposed to 
very large amounts (1000 hemolytic units/ml) of the cell-bound form of strep- 
tolysin S (23). Chromium release induced by mixtures of hydrogen peroxide 
and SLS was totally inhibited either by hydrogen peroxide scavengers [catalase, 
Mn 2+ (70), DMTU (71)] or by trypan blue (a strong inhibitor of SLS) (27). 
Since proteinases were found to markedly enhance tumor cell killing when 
streptolysin S was also present (32, 45), we tested the combined effects of SLS, 
hydrogen peroxide, and trypsin on BGM cells. Figure 1 also shows that while 
trypsin alone (not shown), mixtures of trypsin and SLS, or mixtures of trypsin 
and hydrogen peroxide, at the concentration tested, were only slightly cytotoxic, 
the simultaneous presenze of all three reagents induced distinct synergistic cell 
killing as expressed by the very high percentage of chromium released. The 
exposure of the monolayers to trypsin alone caused cell monolayer shrinkage 
but no cytopathic changes were obvious (Figure 5). The simultaneous presence 
of catalase, trypan blue. and SBTI totally inhibited the synergistic cell killing. 
BGM cells treated by raixtures of GO, SLS, and trypsin were detached from 
the plate surfaces already at the early stages of incubation, presumably due to 
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Fig. 5. BGM cells incubated for 90 min with trypsin (25 /zg/ml). Note shrinking of the culture 
monolayer, but no cytopathic changes are seen (• 250). 
proteinase activity (72). The detached cells were then found to undergo several 
stages of disintegration (Figure 6). The altered cellular morphology was essen- 
tially similar to that previously found with tumor cells (32). Under similar 
experimental conditions, a synergistic release of chromium from the cells also 
took place when sublytic concentrations either of histone, chlorhexidine (a 
cationic antiseptic) PLC, PLA2, or lysophosphatides were combined with sub- 
lytic amounts of hydrogen peroxide and with crystalline trypsin (not shown). In 
all cases, cytotoxicity was markedly depressed by hydrogen peroxide scavengers 
(catalase, DMTU, Mn 2+) but not by SOD. 
Similar synergistic killing of BGM cells also took place when an additional 
source of an oxidant, xanthine-xanthine oxidase, was combined with SLS (Fig- 
ure 7A). The combined effect of PLC and GO on BGM ceils is also shown 
(Figure 7B). Synergistic killing of BGM cells also took place when mixtures of 
paraquat and SLS were employed (Figure 8). Paraquat is known to generate 
superoxide (67), which dismutates to hydrogen peroxide. 
Since mammalian cells are able to repair minor cellular damage that is 
induced by various noxious agents (73-75) and since cell repair depends on 
active cell metabolism, we also tested the possibility that glucose-starved cells 
might become more susceptible to the synergistic effects of oxidants and mem- 
brane-active agents. BGM cells were preincubated for 4 h with 5 mg/ml of 
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Fig. 6. BGM cells incubated for 90 min with a mixture of SLS (50 units/ml), GO (0.5 units/ml), 
and trypsin (25 #g/ml). Note destmction the culture monolayer and the accumulation of cell ghosts 
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Fig. 7. (A) The combined effect of xanthine (5 mM) + xanthine oxidase (0.06 units/ml) and 
streptolysin S (SLS) (50 unils/ml) on chromium release from BGM cells. Note that while SOD 
failed to inhibit cell killing, Mn 2+ at 1 mM totally depressed cell killing. The data are the average 
of three experiments. (B) Th,e combined effect of  GO-generated hydrogen peroxide and phospho- 
lipase C (0.5 units/ml) on the killing of BGM cells. Note the distinct synergistic effect between the 
two agents and the inhibition of cell killing either by catalase or by Mn 2+ . The data are average of 
two experiments. 
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Fig. 8. The combined effect of paraqnat and SLS on BGM cells. Increasing concentrations of 
paraquat were combined with SLS (50 units/ml) and incubated for 90 rain. Note the synergistic 
chromium release by this combination and the inhibition by catalase of cell killing. The data are 
average of three experiments. 
6-deoxyglucose. The monolayers were then exposed either to mixtures of hydro- 
gen peroxide and SLS or to PLC and H202. It was found that whereas glucose- 
starved cells did not become more susceptible to killing by hydrogen peroxide 
alone, such cells were killed in a synergistic manner when challenged by mix- 
tures of hydrogen peroxide and the membrane-active agents PLC or SLS. These 
results are similar to those described previously for deoxyglucose- or puromycin- 
treated endothelial cells (42). 
The role of the endogenous antioxidant, catalase, in cellular defense against 
the synergistic effects of hydrogen peroxide and membrane-active agents (SLS, 
PLC) was also tested by pretreating the ceils either with sodium azide or with 
aminotriazol (potent catalase inhibitors). Such cells became very susceptible not 
only to the effect of hydrogen peroxide alone but mainly to the synergistic effects 
between hydrogen peroxide and the membrane-active agents (not shown). These 
results are similar to those described by us, showing that azide-treated fibrosar- 
coma cells became highly susceptible to killing by activated neutrophils (72). 
These experiments suggest, therefore, that synergistic cell killing by oxidants 
and membrane-active agents is not restricted to endothelial cells (40-42). 
Experiments with Rat Beating Heart Cells. Under similar experimental 
conditions, beating heart cells exposed to subtoxic concentrations of hydrogen 
peroxide were also killed in a synergistic manner by the addition of sublytic 
concentrations of SLS, PLC, histone, or chlorhexidine. As in the case of the 
BGM cells, putative inhibitors of hydrogen peroxide (catalase, DMTU, and 
Mn ~+) totally depressed the synergistic cell killing. The morphological changes 
induced in the heart cells by the mixtures of oxidants and membrane-active 
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agents were similar to those induced in BGM cells showing the development of 
blebs (23, 77), in which cessation of beating appeared much earlier than chro- 
mium release. 
DISCUSSION 
The data presented further support our previous observations with endo- 
thelial cells and show that two additional cell types (epithelial cells and heart 
cells) can be killed, in a synergistic manner, if treated simultaneously by oxi- 
dants and by membrane-active agents. This model system mimics, to some 
extent, that which employed endothelial or epithelial cells and activated human 
neutrophils as reported by many investigators (reviewed in 55 and 59). Our most 
significant observation was the synergy among hydrogen peroxide, a membrane- 
active agent like SLS, and a proteinase (Figures 1, 4, and 6). Proteinases can 
presumably enhance the digestion of oxidant-damaged or denatured membrane 
components. The role played by mixtures of oxidants and proteinases in cellular 
destruction has been addressed by several investigators (43-45, 55). It has also 
been suggested that oxidants released from activated leukocytes might destroy 
proteinase inhibitors and thus facilitate depolymerization of protein structures 
upon cells (55). 
To evaluate the role played by multiple synergistic effects among various 
agonists, an appraisal should be made of the mechanisms by which each indi- 
vidual component of the cocktail is capable, under set conditions, to injure cells. 
The biochemical changes that take place in cells exposed to hydrogen 
peroxide alone were reviewed (73-75). The interaction of mammalian cells with 
hydrogen peroxide was found to cause activation of the hexose monophosphate 
shunt, indicating increased glutathione cycle activity. The DNA strand breaks 
initiated by the peroxide resulted in the activation of the DNA repair enzyme 
poly-ADP polymerase. In parallel, a decrease of ATP was observed that was 
probably due to the ina:tivation of glyceraldehyde-3-dehydrogenase leading to 
inhibition of the glycolytic pathway. In addition, mitochondria became frag- 
mented (76). Minutes following the addition of hydrogen peroxide, free intra- 
cellular calcium started 1:o increase. Finally actin polymerization occm:red, which 
was parallel to the formation of blebs in the plasma membrane (77). This led 
to enhanced plasma membrane permeability and to cell death. 
Our finding that glucose-starved cells became much more susceptible to 
killing by combination,~ of hydrogen peroxide and SLS but not by hydrogen 
peroxide alone (41) also suggests that impairment of cellular metabolism by 
depriving them of energy sources might, however, not be sufficient to render 
the cells more susceptible to oxidants alone and that additional injuries are 
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needed to destroy the cell membrane. It is noteworthy, however, that glucose- 
starved cells were capable of scavenging the same amounts of hydrogen peroxide 
as untreated cells (to be published). This indicates that the enhanced suscepti- 
bility of glucose-starved cells to combinations of SLS and hydrogen peroxide 
was not due to the depletion of catalase or perhaps of glutathione peroxidase, 
but might be due to the amplification by SLS of sublytic injuries induced by 
hydrogen peroxide. However, the short experiments performed might not rep- 
resent the in vivo events that take place in inflammation under the effect of 
antimetabolites. It is also not known how the metabolic changes induced by 
hydrogen peroxide are related to the enhanced membrane damage obtained by 
membrane-active agents. To explain why the micromolar amounts of hydrogen 
peroxide employed in the current study failed to induce a rapid cytocidal effect 
(a 2-h assay), we have to compare this model with that which tested the effect 
of activated neutrophils on fibrosarcoma cells (72). We found that unless the 
mixtures of endothelial ceils and PMNs were treated with sodium azide to inhibit 
catalase, no substantial killing of the targets took place. This suggests that the 
antioxidant systems of the cells acted as effective scavengers of hydrogen per- 
oxide (72, 78). The PMNs, however, very effectively destroyed the cell mono- 
layer and detached the cells presumably by secreting proteinases (72) (see Figure 
6). This effect, however, was inhibited by adding proteinase inhibitors. Acti- 
vated PMNs might thus enhance the spreading of tumor cells but fail to kill 
them (72). The sources of hydrogen peroxide in our in vitro model, which acted 
in concert with membrane-active agents to kill targets, might be GO, xanthine, 
and xanthine oxidase, or paraquat (Figures 7A, 8). The latter two agents are 
known to generate superoxide and hydrogen peroxide. Since, however, cell 
killing by mixtures of the hydrogen peroxide-generating systems with mem- 
brane-active agents was not inhibited either by SOD or by deferoxamine, but 
was markedly depressed by catalase, DMTU, or by Mn 2 § (hydrogen peroxide 
scavengers), it is suggested that the active oxidant involved was indeed hydrogen 
peroxide. Oxygen-derived species can also induce the generation of peroxidation 
products in the plasma membranes (reviewed in 79). The altered membrane 
lipids might then become more susceptible to the effect of sublytic concentrations 
of membrane-active agents. The vast literature on the role of lipid peroxidation 
in cellular injury is, however, beyond the scope of the present communication. 
How do membrane-active agents (phospholipases, microbial hemolysins, cationic 
proteins) augment cellular injury induced by sublytic concentrations of hydrogen 
peroxide? An extensive literature is available on the mechanisms by which 
phospholipases and microbial hemolysins injure red blood cells and kill nucleated 
cells (80, 81). Phosopholipases are known to selectively hydrolyse membrane 
phospholipids and to generate lysophosphatides (PLA2 action) and other deg- 
radation products of phospholipids (PLC action), etc. The breakdown of the 
membrane, at distinct sites might be accompanied by enhanced membrane 
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permeability, rendering the cell nonviable. Although it was claimed that PLA 2 
has only a limited capacily to hydrolyze membrane phospholipids in intact cells, 
but not to cause hemolysis of RBC (80, 81), we have demonstrated that hemo- 
lysis by PLA2 can be veldt effective if serum albumin is added. It seems that as 
long as the enzymatically hydrolyzed fatty acid remains within the structure of 
the membrane the lysophosphatides generated cannot exert their lytic effect. On 
the other hand, BGM cells cannot be killed by PLA2 and albumin unless hydro- 
gen peroxide is also pn~sent. Thus nucleated cells differ from RBC in their 
higher resistance to phos]?holipases. However, PLA2 might injure the membrane 
sublethally, which could "prime" the membrane for an oxidant assault. Lyso- 
phosphatides, however, also differ in their ability to perturb membranes. While 
lysophosphatidylcholine, lysophosphatidylinositol, and lysophosphatidylglyc- 
erol were found by us tc be highly hemolytic for human RBC and also capable 
of priming neutrophils for enhanced superoxide generation (50), lysophospha- 
tides, with polar head groups (lysophosphatidylserine, lysophosphatidylethanol- 
amine) were nonhemolytic and nonstimulatory for superoxide generation by 
human PMNs (50). The reason for this paradoxical finding is not known. Thus 
a limited cleavage of membrane phospholipids might be important in cellular 
damage provided that other agents capable of interacting with rnembranes are 
also present. 
The mechanisms by which lysis of targets is induced by SLS is also not 
fully known (20, 23, 81). Since, however, hemolysis of RBC by this hemolysin 
was totally inhibited by lecithin (82), it seems that hemolysis by this toxin 
involves interaction with membrane phospholipids. SLS, however, does not 
possess phospholipase activity (20). 
Our earlier findings (23) that rat beating heart cells in culture could be 
killed, in the absence of added peroxide, when streptococci possessing cell- 
bound SLS were layered upon them suggests that either the close contact between 
the streptococci and the targets allowed a more efficient delivery (transfer) upon 
the cells of the actively :~ynthesized hemolysin or that the streptococci generated 
hydrogen peroxide, wh!tch acted synergistically with the hemolysin to kill the 
cells in a manner similar to that described in Figure 1. The inclusion of hydrogen 
peroxide scavengers together with streptococci might shed light on this problem. 
The mechanisms by which cationic polypeptides injure mammalian mem- 
branes is also not fully understood (10, 83-86). Naturally occurring polycations 
(histones, beta-lysins, leukocyte cationic proteins, defensins) have been shown 
to be highly microbicidal and cytotoxic for a variety of mammalian cells in vitro 
and in vivo, presumably by interacting with the cell membranes (10, 36-39, 
83-86). Certain bactericidal polycations also collaborated with hydrogen per- 
oxide to kill targets (36-39, 84). This might be due to the capacity of polycations 
to induce cross-linking of anionic surface structures, to alter membrane fluidity, 
and to induce altered cellular permeability (10, 84), which might be markedly 
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augmented by oxidants, as shown when mixtures of hydrogen peroxide with 
histone, chlorhexidine, or polymyxin B, all cationic in nature, were employed 
(40-42). 
Polycations have also been found to enhance the adherence of streptococci 
possessing cell-bound hemolysin (SLS) upon endothelial cells, which markedly 
enhanced cell killing in collaboration with hydrogen peroxide (41). Leukocyte- 
derived polycations might also enhance the binding of nonactivated PMNs to 
cell surfaces in sites of inflammation (87), activate the oxidative burst (10), and 
thus enhance the delivery of oxidants and lysosomal hydrolases directly upon 
the targets. 
Taken together, it might be speculated that under in vivo conditions the 
simultaneous release by activated leukocytes of a multiplicity of agonists (oxi- 
dants, phospholipases, proteinases, and cationic proteins) might act in concert 
to induce enhanced cell and tissue injury similar to that induced in the more 
simplified tissue culture cell models described. The presence of proteinase inhib- 
itors in serum (55) and the availability of antioxidants in cells might, however, 
mitigate the toxic effects induced by the multiple synergistic interactions 
described. Nevertheless to further enhance the antiinflammatory effects of such 
inhibitors, it is suggested that cocktails comprised of (1) antioxidants (catalase, 
SOD, beta-carotene, DMTU, Mn 2+, and synthetic inhibitors of myeloperoxi- 
dase) (reviewed in Ref. 55), (2) both natural and recombinant proteinase inhib- 
itors (55), (3) putative inhibitors of phospholipases A 2 and C, and (4) anionic 
polyelectrolytes to neutralize polycations be concocted. 
Preliminary experiments have shown (41) that a cocktail of agonists com- 
prised of GO-generated hydrogen peroxide, histone, PLC, lysolecithin, and 
trypsin, which acted as a "superkiller" of endothelial cells, could not be totally 
neutralized unless a cocktail of inhibitors comprised of catalase, heparin, chlor- 
oquine, phosphatidylserine, soybean trypsin inhibitor, and 50% fetal calf serum 
were present in the reaction mixtures. This suggests that such cocktails might 
perhaps also be effective in in vivo models yet to be constructed. 
The introduction of novel and more potent forms of scavengers of oxygen- 
derived species such as PEG-catalase and PEG-SOD has been reported (for 
reviews see 88-90). Catalase and SOD that had been cationized by the carbo- 
diimide method proved beneficial against chronic erosive arthritis in rats (91) 
and the cationization of catalse by complexing with poly-L-histidine (92) also 
proved highly protective against oxidant cell killing in in vitro models. The 
employment of dimethylthiourea and thiourea ameliorated lung injury due to 
oxidants (71), and mixtures of glycine and divalent manganese proved beneficial 
for the protection of rat lungs against oxidant stress generated by glucose oxidase 
(70). Thus, these novel agents might also be added to the inhibitory cocktails, 
for in vivo treatments. 
The novel concept of the role played by multiple synergistic interactions 
Synergism and Inflammation 533 
among agonists and their role in pathology might pave the way for a better 
treatment of inflammatol T processes and their sequeallae. 
The recent findings on the role played by cytokines (16, 93, 94) as mod- 
ulators of inflammation .,and the ability of certain cytokines not only to interact 
with one another (95) but to collaborate, in a synergistic manner, with oxidants 
(95-98) and with microbial toxins (98) to enhance cellular damage, open vistas 
and challenges for new approaches to a better understanding of the complexity 
of host and parasite interrelationships. 
Finally, the striking similarities between the pathogenetic mechanisms of 
activated leukocytes and of group A streptococci and, perhaps, also of Clostri- 
dia, suggest that much can still be learned from toxigenic prokaroytes about 
how tissues are invaded and are eventually destroyed. The development of 
effective serotherapy against toxigenic microorganisms might also lead to the 
employment of effective measures against the deleterious effects of leukocyte 
enzymes. From the evolutionary point of view it perhaps might be justified to 
consider toxigenic microorganisms as the forefathers of "modem" leukocytes. 
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